IN2014MN01553A - - Google Patents
Info
- Publication number
- IN2014MN01553A IN2014MN01553A IN1553MUN2014A IN2014MN01553A IN 2014MN01553 A IN2014MN01553 A IN 2014MN01553A IN 1553MUN2014 A IN1553MUN2014 A IN 1553MUN2014A IN 2014MN01553 A IN2014MN01553 A IN 2014MN01553A
- Authority
- IN
- India
- Prior art keywords
- geranylgeranylacetone
- adsorption
- container wall
- inhibited
- lipophilic antioxidant
- Prior art date
Links
- DJAHKBBSJCDSOZ-AJLBTXRUSA-N (5z,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;(5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C/CCC(C)=O.CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O DJAHKBBSJCDSOZ-AJLBTXRUSA-N 0.000 abstract 4
- 229950006156 teprenone Drugs 0.000 abstract 4
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 238000001179 sorption measurement Methods 0.000 abstract 2
- 230000007423 decrease Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
An ophthalmic composition containing a geranylgeranylacetone and a lipophilic antioxidant wherein the adsorption of the geranylgeranylacetone into a container wall is significantly inhibited and as a result the decline in the content or concentration of the geranylgeranylacetone within the composition is significantly inhibited. Moreover the adsorption of the lipophilic antioxidant into the container wall is also inhibited by being combined with the geranylgeranylacetone.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012040675 | 2012-02-27 | ||
| PCT/JP2013/054785 WO2013129322A1 (en) | 2012-02-27 | 2013-02-25 | Ophthalmic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01553A true IN2014MN01553A (en) | 2015-05-08 |
Family
ID=49082519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1553MUN2014 IN2014MN01553A (en) | 2012-02-27 | 2013-02-25 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20130303627A1 (en) |
| JP (2) | JP5345746B1 (en) |
| CN (1) | CN104136016A (en) |
| HK (1) | HK1200109A1 (en) |
| IN (1) | IN2014MN01553A (en) |
| TW (1) | TWI565464B (en) |
| WO (1) | WO2013129322A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014129466A1 (en) * | 2013-02-19 | 2014-08-28 | ロート製薬株式会社 | Mucosal application agent for preventing, ameliorating or treating retinal disease |
| JP5483513B1 (en) * | 2013-02-19 | 2014-05-07 | ロート製薬株式会社 | Mucosal application agent for prevention, improvement, or treatment of retinal diseases |
| WO2015029924A1 (en) * | 2013-08-26 | 2015-03-05 | ロート製薬株式会社 | Ophthalmological composition |
| JPWO2015029926A1 (en) * | 2013-08-26 | 2017-03-02 | ロート製薬株式会社 | Ophthalmic composition |
| TW201542196A (en) * | 2013-08-26 | 2015-11-16 | Rohto Pharma | Ophthalmic formulation |
| US9421199B2 (en) * | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| US20190350881A1 (en) | 2016-06-17 | 2019-11-21 | Ys Pharmtech | Stabilization of epinephrine formulations |
| TW201807458A (en) * | 2016-08-26 | 2018-03-01 | 鴻海精密工業股份有限公司 | Ophthalmic lens, intraocular lens and package containing ophthalmic lens |
| CN115322095A (en) * | 2021-01-27 | 2022-11-11 | Agc株式会社 | Purification method of tafluprost |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3734521B2 (en) * | 1993-12-21 | 2006-01-11 | 千寿製薬株式会社 | Eye drops |
| JP3021312B2 (en) * | 1994-03-15 | 2000-03-15 | 千寿製薬株式会社 | Method for stabilizing pranoprofen and stable aqueous solution of pranoprofen |
| JPH08133967A (en) * | 1994-11-02 | 1996-05-28 | Eisai Co Ltd | Agent for treating dry eye |
| JP3880265B2 (en) * | 1998-11-16 | 2007-02-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Aqueous solution of fat-soluble substances |
| JP2000319170A (en) * | 1999-03-05 | 2000-11-21 | Eisai Co Ltd | Teprenone-containing eye lotion |
| JP3876355B2 (en) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | Ophthalmic solution |
| WO2010150378A1 (en) * | 2009-06-25 | 2010-12-29 | ライオン株式会社 | Ophthalmic composition |
-
2013
- 2013-02-25 JP JP2013510418A patent/JP5345746B1/en active Active
- 2013-02-25 HK HK15100633.6A patent/HK1200109A1/en unknown
- 2013-02-25 CN CN201380011315.XA patent/CN104136016A/en active Pending
- 2013-02-25 TW TW102106506A patent/TWI565464B/en not_active IP Right Cessation
- 2013-02-25 IN IN1553MUN2014 patent/IN2014MN01553A/en unknown
- 2013-02-25 WO PCT/JP2013/054785 patent/WO2013129322A1/en not_active Ceased
- 2013-02-25 US US13/775,644 patent/US20130303627A1/en not_active Abandoned
- 2013-07-12 JP JP2013147011A patent/JP2013231067A/en active Pending
-
2014
- 2014-10-06 US US14/506,731 patent/US20150025154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104136016A (en) | 2014-11-05 |
| WO2013129322A1 (en) | 2013-09-06 |
| JPWO2013129322A1 (en) | 2015-07-30 |
| JP5345746B1 (en) | 2013-11-20 |
| US20130303627A1 (en) | 2013-11-14 |
| TW201340961A (en) | 2013-10-16 |
| US20150025154A1 (en) | 2015-01-22 |
| HK1200109A1 (en) | 2015-07-31 |
| JP2013231067A (en) | 2013-11-14 |
| TWI565464B (en) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01553A (en) | ||
| AU345438S (en) | Container | |
| AU345660S (en) | Container | |
| AU345570S (en) | Container | |
| AU345585S (en) | Container | |
| AU345568S (en) | Container | |
| AU345599S (en) | Container | |
| AU345587S (en) | Container | |
| AU345517S (en) | Container | |
| AU345559S (en) | Container | |
| AU344784S (en) | Container | |
| AU345519S (en) | Container | |
| AU354932S (en) | Container overwrap | |
| AU341100S (en) | Food container | |
| AU345364S (en) | Autoinjector | |
| AU345363S (en) | Autoinjector | |
| AU344786S (en) | Container | |
| AU345531S (en) | Container | |
| AU354508S (en) | Container | |
| AU349974S (en) | Container | |
| MY168019A (en) | Implement for Constant-Temperature Storage and Storage Container Housing the Same | |
| AU354689S (en) | Container | |
| AU354964S (en) | Container | |
| AU340610S (en) | Container | |
| AU355031S (en) | Container |